This study showed that CHRE improved cognitive impairments in Aβ1–42-induced rats through decreased Aβ1–42 protein levels and neuroinflammation, particularly the expressions of CD11b-positive microglia, IL-1β, and TNFα in the cerebral cortex and hippocampus. The gene discussed is TNF; the disease is Cognitive impairment.